Skip to Content
Culture

Building something extraordinary

We are a team of passionate pioneers and life-long learners who are trailblazing the future of precision medicine. The research and therapies we’re advancing represent a unique opportunity to fundamentally change treatment paradigms for cancer and other serious diseases, and therefore to impact countless people’s lives around the world.

We approach our work with passion, humility and awe. From our drive to develop transformative medicines, to the way we interact with each other and in our communities, we are a team that comes together in expected and unexpected ways, united by a shared purpose to make a difference.

The people that make Parabilis

“After college, I coordinated clinical trials during the early days of DNA sequencing technology. This ground-breaking technology, combined with my experience working with patients, inspired me to pursue computational biology and work with scientists here who are pushing the boundaries for new treatments.”

David Ballard, Ph.D. Senior Director of Data Science
sonia

“I’m driven by the opportunity to create real value for patients through breakthrough treatments fueled by collaborations that harness the power of science to make a meaningful impact.”

Sonia Parekh Associate Director of Business Development and Alliance Management
santosh

“I am excited to be part of developing Helicon medicines that can be rapidly optimized into the ideal chemical space while precisely targeting a wide range of protein-protein and protein-DNA interactions.”

Santosh Choudary, Ph.D. Associate Director, De Novo Discovery

“Our science is groundbreaking, and our mission is inspiring, but I think it’s our team that really sets us apart. The dedication and camaraderie I see every day motivates me to be the best version of myself.”

Tara Travaline Scientist I

We see the tremendous opportunity for impact and are driven by the incredible responsibility to make it happen

Our core values

They’re not merely words on a slide — our core values are the essence of Parabilis’s culture, which we weave into the everyday scientific, clinical and business activities of the company and into how we approach each of our roles.

Growth-Minded

We’re inventing a new class of medicines — one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.

In(ter)dependent

We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.

Patient-Focused

We are deeply focused on patient outcomes, and all energy in the company is focused on translating science to patient impact.

All-In

We’re fully dedicated to solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

Parabilis at work and at play

Our passion for creativity and love of learning mean growth and opportunities flourish at Parabilis! To keep up with our updates, follow us on LinkedIn.

?>
EricSchadt

We were honored to host Eric Schadt, a leading figure in computational biology and precision medicine, at our offices recently. In his current roles as CSO of Pathos, Dean for Precision Medicine at the Icahn School of Medicine at Mount Sinai, and across the rest of his distinguished career, Dr. Schadt has driven innovation in the use of data science to pair precise patient populations with more targeted interventions — something we’re passionately advancing here at FogPharma as well.

We were very grateful to have Regina Barzilay — one of the world’s leading AI/machine learning researchers and a Distinguished Professor for AI and Health at CSAIL MIT — join us recently to discuss the fast-evolving landscape of machine learning in drug discovery. Dr. Barzilay presented some of her own pioneering work in building AI models to optimize small-molecule drug design and protein engineering.

We were very proud to have TeamFogPharma along with our families and friends walking in the Boston Pride Parade on Saturday! The event was a joyful experience in celebrating PrideMonth, honoring the rich history and many local activists past and present who champion the rights of LGBTQ+ people worldwide, and demonstrating Fog’s commitment to advancing equity and inclusivity for the LGBTQ+ community.

As the world cheered on athletes at #Paris2024, we channeled that same spirit of friendly competition at our 4th annual Summer Olympics last week! Featuring events such as pinning sidechains onto Helicons, a pipette tip shooting contest, and a radiopharmaceutical-inspired relay, our version of the summer games put our creativity and problem-solving to the test and produced lots of opportunities for camaraderie and laughter.